Such circulating tumor cells (CTCs) bypass the cell apoptosis due to cell-matrix or cell-cell interactions losing, resulting in activation of phosphatidylinositol 3-kinases/protein kinase B (PI3K-AKT) pro-survival pathways. This evidence concerns the gene AKT1 and neoplasm.